Development and Validation of a Penicillin Allergy Clinical Decision Rule

JA Trubiano; S Vogrin; KYL Chua; J Bourke; J Yun; A Douglas; CA Stone; R Yu; L Groenendijk; NE Holmes; EJ Phillips

Journal article

Development and Validation of a Penicillin Allergy Clinical Decision Rule

JA Trubiano, S Vogrin, KYL Chua, J Bourke, J Yun, A Douglas, CA Stone, R Yu, L Groenendijk, NE Holmes, EJ Phillips

JAMA Internal Medicine | AMER MEDICAL ASSOC | Published : 2020

DOI: 10.1001/jamainternmed.2020.0403

Abstract

Importance: Penicillin allergy is a significant public health issue for patients, antimicrobial stewardship programs, and health services. Validated clinical decision rules are urgently needed to identify low-risk penicillin allergies that potentially do not require penicillin skin testing by a specialist. Objective: To develop and validate a penicillin allergy clinical decision rule that enables point-of-care risk assessment of patient-reported penicillin allergies. Design, Setting, and Participants: In this diagnostic study, a multicenter prospective antibiotic allergy-tested cohort of 622 patients from 2 tertiary care sites in Melbourne, Australia (Austin Health and Peter MacCallum Cancer..

View full abstract

University of Melbourne Researchers

Jason Trubiano Author

Sara Vogrin Author

Kyra Chua Author

Abby Douglas Author

Related Projects (1)

DEVELOPING AND EVALUATING A MULTIMODAL ANTIBIOTIC ALLERGY STRATEGY TO IMPROVE ANTIMICROBIAL STEWARDSHIP IN HIGH-RISK ANTIBIOTIC USAGE POPULATIONS

Antibiotic allergies lead to the use of inferior antibiotics and generation of “superbugs”. Antibiotic allergy testing removes up to 90% of ..

Grants

Awarded by National Institutes of Health

Funding Acknowledgements

This study was supported by a grant from the Austin Medical Research Foundation (AMRF); postgraduate scholarship GNT 1139902 from the NHMRC (Dr Trubiano); a postgraduate scholarship from the National Centre for Infections in Cancer (Dr Trubiano); grants 1P50GM115305-01, R21AI139021, R34AI136815, and 1R01HG01086301 from the NIH (Dr Phillips); the NHMRC (Dr Phillips); and grant 1K12HS026395-01 from the AHRQ (Dr Stone).